9AT: VESTAL POINT CAPITAL, LP

other names

VESTAL POINT CAPITAL, LP

Adviser Profile

As of Date	03/31/2026
Registration	SEC, Approved, 04/14/2023
Other registrations (1)	SEC, 120-Day Approval, 04/14/2023
ADV Location	NEW YORK, NY, United States
Contact Info	646 xxxxxxx
Websites

AUM^*	5,469,117,378 197%
of that, discretionary	5,469,117,378 197%
Private Fund GAV^*	2,799,059,296 114%
Avg Account Size	1,367,279,345 197%
SMA’s	No
Private Funds	3

Adviser Type

- Large advisory firm

Number of Employees 11 10%

of those in investment advisory functions 8 14%

Client Types

- Pooled investment vehicles
- Other

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

SEC Fund Type	Count	GAV
Fund TypeHedge Fund	Count3	GAV$2,799,059,296

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser NEO-CRITERION CAPITAL LIMITED	Hedge Fund31.8m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV31.8m	AUM31.8m	#Funds2
Adviser HOLDCO ASSET MANAGEMENT, LP	Hedge Fund2.8b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV2.8b	AUM2.8b	#Funds4
Adviser BLUESHIFT ASSET MANAGEMENT	Hedge Fund197.5m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV197.5m	AUM694.4m	#Funds4
Adviser CONDIRE MANAGEMENT, LP	Hedge Fund2.6b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV2.6b	AUM1.9b	#Funds5
Adviser ANCORA ALTERNATIVES LLC	Hedge Fund1.1b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV1.1b	AUM1.1b	#Funds33
Adviser BELSTAR MANAGEMENT COMPANY, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM649.4m	#Funds-
Adviser THIRD AVENUE MANAGEMENT LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM1.6b	#Funds-
Adviser PALO ALTO INVESTORS LP	Hedge Fund692.0m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV692.0m	AUM696.0m	#Funds12
Adviser PRIME CAPITAL MANAGEMENT COMPANY LIMITED	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM1.0b	#Funds-
Adviser NARWHAL CAPITAL MANAGEMENT	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM2.1b	#Funds-

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck Ticker09061G101	Stock NameBioMarin Pharmaceutical Inc	$ Position$201,951,750	% Position6.00%	$ Change13.00%	# Change19.00%
Stck Ticker76155X100	Stock NameRevolution Medicines Inc	$ Position$230,968,750	% Position6.00%	$ Change883.00%	# Change705.00%
Stck Ticker64125C109	Stock NameNeurocrine Biosciences Inc	$ Position$164,675,000	% Position5.00%	$ Change	# Change
Stck Ticker00370M103	Stock NameAbivax SA	$ Position$167,025,000	% Position5.00%	$ Change-35.00%	# Change-21.00%
Stck Ticker04280A100	Stock NameArrowhead Pharmaceuticals Inc	$ Position$142,642,500	% Position4.00%	$ Change139.00%	# Change153.00%
Stck Ticker29337E102	Stock NameEnliven Therapeutics Inc	$ Position$127,400,000	% Position4.00%	$ Change116.00%	# Change-15.00%
Stck Ticker03770N101	Stock NameApogee Therapeutics Inc	$ Position$92,587,000	% Position3.00%	$ Change123.00%	# Change100.00%
Stck Ticker055477103	Stock NameBicara Therapeutics Inc	$ Position$107,903,250	% Position3.00%	$ Change79.00%	# Change52.00%
Stck Ticker67080M103	Stock NameNurix Therapeutics Inc	$ Position$100,750,000	% Position3.00%	$ Change13.00%	# Change39.00%
Stck Ticker759916109	Stock NameRepligen Corp	$ Position$108,983,500	% Position3.00%	$ Change701.00%	# Change1014.00%

Brochure Summary

Overview

Vestal Point Capital, LP (hereinafter “Vestal Point”, “we”, “us”, “our” or the “Firm”) is organized as a Delaware limited partnership with a principal place of business New York, New York. We serve as the investment adviser, with discretionary trading authority, to private, pooled investment vehicles, the securities of which are offered through a private placement memorandum to accredited investors, as defined under the Securities Act of 1933, as amended, and qualified purchasers, as defined under the Investment Company Act of 1940, as amended. We do not tailor our advisory services to the individual needs of any particular investor. Vestal Point manages the following private, pooled investment vehicles:
• Vestal Point Offshore Fund, Ltd., a Cayman Islands exempted company (the “Offshore Fund”);
• Vestal Point Partners, LP, a Delaware limited partnership (the “Onshore Fund”); and
• Vestal Point Master Fund, LP, a Cayman Islands exempted limited partnership (the “Master Fund”). The Master Fund, the Onshore Fund and the Offshore Fund are herein each referred to as a “Fund”, and collectively referred to as the “Funds”. The Onshore Fund’s “Limited Partners” and the Offshore Fund’s “Shareholders” are hereafter collectively

referred to as the “Investors” where appropriate. Our investment decisions and advice with respect to the Funds are subject to each Fund’s investment objectives and guidelines, as set forth in its respective “Offering Documents.” Vestal Point also provides investment advisory services to a separately managed account (the “Account”, and collectively with the Funds, the “Clients”) that is managed according to an investment advisory agreement (the “Advisory Agreement” and, collectively with the Offering Documents, the “Governing Documents”). Generally, in the normal course of business, the Account and the Funds will be managed pari-passu. However, there may be exceptions that could lead to non-pari-passu investments due to certain risk management parameters such as drawdowns, leverage, cash availability, liquidity, stop losses or profit targets, restricted lists, or periods of grossing up/down of the portfolio due to capital flows. Vestal Point may also accept other clients, including additional private funds, at any time. We do not currently participate in any Wrap Fee Programs. As of December 31, 2023, the Firm has regulatory assets under management of $1,841,931,516, all of which is managed on a discretionary basis.

VESTAL POINT CAPITAL, LP

Adviser Profile

Details

Adviser Type

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview